Related Experiment Video
Updated: Aug 12, 2026
06:58
Culturing and Measuring Fetal and Newborn Murine Long Bones
Published on: April 26, 2019
Ontogenetic limb bone scaling in basic fibroblast growth factor (FGF-2) transgenic mice
P S Lightfoot1, R Swisher, J D Coffin
1Department of Biological Sciences, University of Cincinnati, OH 45221-0006, USA.
Growth, Development, and Aging : GDA
|April 18, 1998
Summary
Overexpressing basic fibroblast growth factor (FGF-2) in mice resulted in shorter, wider limb bones. These skeletal changes were linked to early growth parameters, not overall body weight.
Area of Science:
- Skeletal Biology
- Developmental Biology
- Genetics
Background:
- Basic fibroblast growth factor (FGF-2) is crucial for skeletal development.
- Inhibition of FGF-2 signaling leads to skeletal malformations.
- Understanding FGF-2's role requires studying its overexpression effects.
Purpose of the Study:
- To investigate the impact of FGF-2 overexpression on limb bone development in transgenic mice.
- To analyze specific bone dimensions and growth parameters.
Main Methods:
- Utilized FGF-2 transgenic mice.
- Collected longitudinal radiographic and weight data.
- Applied the Gompertz mathematical model to analyze growth kinetics.
- Used ANOVA to test for differences between genotypes and sexes.
Main Results:
- Transgenic mice exhibited shorter limb bones (humerus, femur, tibia) compared to controls.
- Limb bones were generally wider at the epiphyses in transgenic mice.
- Early growth parameters (initial size, growth rate) significantly influenced final bone size.
- No significant differences in body weight were observed between genotypes.
Conclusions:
- FGF-2 overexpression directly impacts limb bone ontogeny, leading to distinct skeletal anomalies.
- Altered early growth dynamics are the primary drivers of size differences.
- The observed effects are specific to FGF-2 action, not a general growth retardation.
